Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4249012 | Revista Española de Medicina Nuclear | 2010 | 4 Pages |
Abstract
In order to correctly interpret PET/CT studies, knowledge of the biodistribution of 18F-fluorodeoxyglucose (FDG), the physiological variants as well as the pitfalls, including artefacts, which may be found, is necessary. We report four cases performed during the follow-up diagnostic context of an oncology study performed with 18F-FDG-PET/CT. In every case, this study showed focal uptake in the lung parenchyma in the PET study with no structural lesions being found on the CT scan. Radiotracer extravasation in three of these patients and a recent change in the injection protocol used suggest that an artefact was responsible for these discrepancies.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
R. Sánchez-Sánchez, A. RodrÃguez-Fernández, Á. RamÃrez-Navarro, M. Gómez-RÃo, C. Ramos-Font, J.M. Llamas-Elvira,